Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
Clinical trial NCT01048099 · COMPLETED
Trial details
- NCT number
- NCT01048099
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2014-07-01
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.